Enfortumab Vedotin
NCT06891560
Memorial Sloan Kettering · Phase 2 · Recruiting · Enrollment 34
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
Enfortumab Vedotin
Memorial Sloan Kettering · Phase 2 · Recruiting · Enrollment 34
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.